Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Randomized, Open-label Study to Prove an Additional Benefit of the Full-spectrum Cannabis Extract VER-01 Over Opioids in the Treatment of Patients With Chronic Non-specific Low Back Pain

NCT05610813 is registered in ClinicalTrials.gov with Vertanical GmbH as lead sponsor.

NCT NCT05610813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05610813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Randomized, Open-label Study to Prove an Additional Benefit of the Full-spectrum Cannabis Extract VER-01 Over Opioids in the Treatment of Patients With Chronic Non-specific Low Back Pain
Lead sponsor
Vertanical GmbH
Phase
Phase 3
Overall status
Completed
Start date
June 8, 2023
Completion date
October 18, 2024
Enrollment
384 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic non-specific low back pain